639820-24-9

Upstream product

• 501-53-1 benzyl chloroformate 
• 58479-61-1 tert-butylchlorodiphenylsilane 
• 639820-23-8 (1R,4S,5S)-4-[(tert-butyldiphenylsilyloxy)methyl]-6-(3',4'-dimethoxybenzyl)-3-oxa-6-azabicyclo[3.1.0]hexan-2-one 
• 5336-08-3 D-Ribono-1,4-lactone 
• 92512-33-9 (3R,4S,5R)-5-((tert-butyldiphenylsilyloxy)methyl)-3,4-dihydroxydihydrofuran-2(3H)-one 
• 639820-22-7 (S)-5-((tert-butyldiphenylsilyloxy)methyl)-2-oxo-2,5-dihydrofuran-3-yl trifluoromethanesulfonate 

Downstream Products

• 639820-25-0 3-O-allyl-2-N-(benzyloxycarbonyl)amino-5-O-(tert-butyldiphenylsilyl)-2-deoxy-D-xylono-1,4-lactone 
• 639820-27-2 2-N-(benzyloxycarbonyl)amino-2-deoxy-D-xylono-1,4-lactone 
• 639820-26-1 2-N-(benzyloxycarbonyl)amino-5-O-(tert-butyldiphenylsilyl)-2-deoxy-D-xylono-1,4-lactone 
• 1141897-49-5 (3S,4R,5S)-3-acetoxy-4-[(benzyloxycarbonyl)amino]-5-[(tert-butyldiphenylsilyloxy)methyl]tetrahydrofuran-2-one 
• 866944-19-6 (1R,4S,5S)-2-Oxo-4-(toluene-4-sulfonyloxymethyl)-3-oxa-6-aza-bicyclo[3.1.0]hexane-6-carboxylic acid benzyl ester 
• 866944-18-5 (1S,2S,5R)-2-Hydroxymethyl-4-oxo-3-oxa-6-aza-bicyclo[3.1.0]hexane-6-carboxylic acid benzyl ester 

Relevant academic research and scientific papers

Enantiospecific synthesis of a protected equivalent of APTO, the β-amino acid fragment of microsclerodermins C and D, by aziridino-γ-lactone methodology

The efficient synthesis of a protected form of (2S,3R,4S,5S,7E)-3-amino-8- phenyl-2,4,5-trihydroxyoct-7-enoic acid (APTO), the α-hydroxy β-amino acid component of microsclerodermins C and D, 23-membered cyclic peptides isolated from lithistid sponges, is

Enantiospecific Total Synthesis of (-)-Polyoxamic Acid Using 2,3-Aziridino-γ-lactone Methodology

The non-natural enantiomer of polyoxamic acid was synthesized in six steps from 2,3-aziridino-γ-lactone 7 with an overall yield of 10%. The key step of the strategy is a deprotection-protection sequence on the nitrogen atom of the aziridine ring required